Have you ever worried about hypoglycemia occurring overnight? Ever wished there was a way that you could prevent night time episodes?
If you have answered ‘yes’, then we may have a research study opportunity for you!
Hypoglycemia is a major barrier to optimal blood sugar control in people living with Type 1 Diabetes. Studies suggest that approximately half of these episodes occur at night while people are asleep, and may be undetected. While there are glucagon products available to treat severe hypoglycemia, and newer insulins are associated to reduction in hypoglycemia occurrences, there are no available options to prevent hypoglycemia in Type 1s.
In response to this unmet need, we are testing an investigational medication as a daily injection to prevent night time hypoglycemia.
This is a great opportunity for you to have access to investigational technology and possibly contribute to the improvement of future diabetes treatments! If you’re interested in obtaining more information about one of our clinical research programs, call us (1-833-323-JOIN) or email us at email@example.com.
Best wishes for your continued good health,
The Clinical Research Teams
LMC Manna Research
“Improving the health of Canadians today and tomorrow through clinical research.”